References
- Hoogstraten B, Fabian C. A reappraisal of single drugs in advanced breast cancer. Cancer Clin Trials 1979; 2: 101–9.
- Marini G, Simoncini E, Zaniboni, A et al. 5-Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update. Oncology 1987; 44: 336–40.
- Swain SM, Lippman ME, Chabner BA et al. Salvage treatment of patients with metastatic breast cancer with 5- fluorouracil and high-dose Leucovorin. Proc Am Soc Clin Oncol 1988; 7: 221.
- Doroshow J, Leong L, Margolin K et al. Effective salvage therapy for refractory metastatic breast cancer with high-dose continuous infusion folinic acid (HDFA) and intravenous bolus 5-Fluorouracil (FUra). Proc Am Soc Clin Oncol 1988; 7: 129.
- Grem JL, Fisher PH. Augmentation of 5-Fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Cancer Res 1985; 45: 2967–72.
- Remik SC, Grem JL, Fisher PH et al. A phase I trial of concurrent continuous infusion of 5-Fluorouracil and Dipyridamole. Proc Am Assoc Cancer Res 1987; 28: 227.
- WHO Handbook for reporting results of cancer treatment. WHO offset publication, N. 48 (WHO, Geneva, 1979).
- Schwartz J, Alberts D, Einspahr J et al. Dipyridamole (D) potentiation of FUdR activity against human colon cancer in vitro and in patients. Proc Am Soc Clin Oncol 1987; 6: 325.
- Willson JKV, Fisher PH, Tutsch K et al. Phase I clinical trial of a combination of Dipyridamole and Acivicin based upon inhibition of nucleoside salvage. Cancer Res 1988; 48: 5585–90.